Few family physicians are making low-dose CT screening referrals to patients who are at high risk for lung cancer.
Although the majority of family physicians discuss the use of low-dose CT (LDCT) lung cancer screening with high-risk patients, referrals for screening remain low, according to a study published in Cancer.
Researchers from South Carolina sought to assess the level of knowledge of LDCT use for high-risk patients, and the physicians’ attitudes towards and use of the screening tool. The researchers sent out a 32-item questionnaire to members of the South Carolina Academy of Family Physicians; 101 responses were received.
The results showed that most of the respondents had incorrect knowledge about which organizations recommended screening, and many continued to recommend chest X-ray for lung cancer screening. Although 76% of the physicians did discuss the risks/benefits of screening, fewer than 50% said they made only one or no screening recommendations over the year prior to completing the survey.
Most physicians (98%) felt that LDCT screening increased the odds of detecting disease at earlier stages and that the benefits did outweigh the harms (75%). However, they listed concerns related to the procedure, believing that they could result in:
• Unnecessary procedures (88%)
• Stress/anxiety (52%)
• Radiation exposure (50%)
The researchers concluded that although most family physicians did understand the need for early lung cancer screening with LDCT and had discussions with their patients, few referred their patients for the imaging tests.
“There are gaps in physician knowledge about screening guidelines and reimbursement, and this indicates a need for further educational outreach,” they wrote. “The development of decision aids may facilitate shared decision-making discussions about screening, and targeted interventions may improve knowledge gaps.”
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.